ENGINEERED ENZYME
    24.
    发明申请

    公开(公告)号:US20220098562A1

    公开(公告)日:2022-03-31

    申请号:US17551391

    申请日:2021-12-15

    Abstract: The present disclosure provides a novel catalytically inactive MAD7 nuclease (dMAD7) that retains the ability to bind DNA in a sequence-specific manner. The MAD7 nuclease from which the dMAD7 has been derived was isolated from Eubacterium rectale.

    METHODS FOR INCREASING OBSERVED EDITING IN BACTERIA

    公开(公告)号:US20220081693A1

    公开(公告)日:2022-03-17

    申请号:US17536067

    申请日:2021-11-28

    Abstract: The present disclosure relates to methods for increasing observed editing rates in the surviving bacteria cells. The compositions and methods presented herein in combination lead to a phenomenon of “edit or die.” Although less cells survive plating and editing, a large percentage of cells that do survive are multiple editors. In one experiment it was found that if a cell survives transformation, plating, and editing, 75% of the surviving cells are multiple editors; that is, 75% of the surviving cells were simultaneously edited with edits at two or more different locations within the bacterial genome

Patent Agency Ranking